Hs-CRP and HOMA-IR: Include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?
Heng Wan, Zihao Gui, Lan Liu, Ningjian Wang, Jie Shen
Topics & Concepts
Atherosclerotic cardiovascular diseaseDiseaseMedicineIntensive care medicineInternal medicineLiver Disease Diagnosis and TreatmentCardiovascular Disease and AdiposityLipid metabolism and disorders